eMagin (NYSEAMERICAN:EMAN) Trading 10.2% Higher

Share on StockTwits

eMagin Co. (NYSEAMERICAN:EMAN) traded up 10.2% during trading on Monday . The stock traded as high as $0.85 and last traded at $0.83, 1,425,056 shares changed hands during mid-day trading. A decline of 46% from the average session volume of 2,620,109 shares. The stock had previously closed at $0.75.

Separately, Zacks Investment Research cut eMagin from a “buy” rating to a “hold” rating in a research note on Friday, May 29th.

eMagin (NYSEAMERICAN:EMAN) last announced its quarterly earnings data on Thursday, May 14th. The semiconductor company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The firm had revenue of $6.73 million during the quarter. During the same quarter in the previous year, the company posted ($0.03) EPS.

An institutional investor recently raised its position in eMagin stock. Renaissance Technologies LLC lifted its stake in shares of eMagin Co. (NYSEAMERICAN:EMAN) by 41.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 243,071 shares of the semiconductor company’s stock after purchasing an additional 71,741 shares during the period. Renaissance Technologies LLC owned 0.49% of eMagin worth $84,000 at the end of the most recent quarter.

eMagin Company Profile (NYSEAMERICAN:EMAN)

eMagin Corporation designs, develops, manufactures, and markets organic light emitting diode (OLED) displays on-silicon micro displays; virtual imaging products that utilize OLED micro displays; and related products. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS and OLED-XL; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL/XLS.

Further Reading: What is the cash asset ratio?

Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Zacks: Brokerages Anticipate Enanta Pharmaceuticals Inc  to Post -$0.65 Earnings Per Share
Zacks: Brokerages Anticipate Enanta Pharmaceuticals Inc to Post -$0.65 Earnings Per Share
Zacks: Analysts Expect La Jolla Pharmaceutical  Will Announce Earnings of -$0.77 Per Share
Zacks: Analysts Expect La Jolla Pharmaceutical Will Announce Earnings of -$0.77 Per Share
Equities Analysts Set Expectations for HarborOne Bancorp Inc’s Q3 2020 Earnings
Equities Analysts Set Expectations for HarborOne Bancorp Inc’s Q3 2020 Earnings
Research Analysts Offer Predictions for M&T Bank Co.’s Q3 2020 Earnings
Research Analysts Offer Predictions for M&T Bank Co.’s Q3 2020 Earnings
Unisys  Shares Up 6.5%
Unisys Shares Up 6.5%
Meredith  Shares Up 6.5%
Meredith Shares Up 6.5%


© 2006-2020 Ticker Report